Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

CMS announces decision on anti-amyloid monoclonal antibodies – UCI MIND,

Two Phase 3 clinical trials of the drug were discordant — one suggested a benefit and the other did not. The FDA approved aducanumab through the …, Two Phase 3 clinical trials of the drug were discordant — one suggested a benefit and the other did not. The FDA approved aducanumab through the …, Read More

Scroll to Top